Zimmer Biomet (ZBH) said Wednesday that the US Food and Drug Administration granted 510 (k) clearance to Persona SoluTion Porous Plasma Spray Femur.
The total knee implant, which features a porous coating for cementless fixation, offers an option for patients with sensitivities to bone cement and/or metal, according to the company.
The company said Persona SoluTion PPS Femur will be commercially available in the US in Q1.
Shares of Zimmer Biomet were up 1% in recent trading.
Price: 111.86, Change: +1.12, Percent Change: +1.01
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.